Which has preferable valuation & earnings, NVST or ALGN?

Align Technology has higher revenue and earnings than Envista. Align Technology is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Envista $2.72B 1.52 $47M $0.41 61.78 Align Technology $4.03B 2.99 $410.35M $5.96 28.27

Is BRBR or NVST more profitable?

BellRing Brands has a net margin of 6.78% compared to Envista's net margin of 2.41%. Envista's return on equity of 7.11% beat BellRing Brands' return on equity. Company Net Margins Return on Equity Return on Assets BellRing Brands 6.78% -44.06% 19.42% Envista 2.41% 7.11% 3.91%

Which has better earnings and valuation, NVST or SOLV?

Solventum has higher revenue and earnings than Envista. Solventum is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Envista $2.72B 1.52 $47M $0.41 61.78 Solventum $8.33B 1.54 $1.56B $8.16 9.09

Is NVST or SOLV more profitable?

Solventum has a net margin of 17.33% compared to Envista's net margin of 2.41%. Solventum's return on equity of 23.51% beat Envista's return on equity. Company Net Margins Return on Equity Return on Assets Envista 2.41% 7.11% 3.91% Solventum 17.33% 23.51% 7.63%

Which has better earnings & valuation, SNN or NVST?

Smith & Nephew SNATS has higher revenue and earnings than Envista. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Smith & Nephew SNATS $6.16B 2.04 $625M N/A N/A Envista $2.72B 1.52 $47M $0.41 61.78

Envista (NVST) Competitors

$25.33 -0.18 (-0.71%)

As of 03:58 PM Eastern

Compare

NVST vs. ALGN, XRAY, BRBR, SOLV, and SNN

Should you buy Envista stock or one of its competitors? MarketBeat compares Envista with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Envista include Align Technology (ALGN), DENTSPLY SIRONA (XRAY), BellRing Brands (BRBR), Solventum (SOLV), and Smith & Nephew SNATS (SNN).

How does Envista compare to Align Technology?

Envista (NYSE:NVST) and Align Technology (NASDAQ:ALGN) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and media sentiment.

88.4% of Align Technology shares are held by institutional investors. 1.0% of Envista shares are held by insiders. Comparatively, 0.8% of Align Technology shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Align Technology has a net margin of 10.50% compared to Envista's net margin of 2.41%. Align Technology's return on equity of 15.82% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	2.41%	7.11%	3.91%
Align Technology	10.50%	15.82%	10.17%

Align Technology has higher revenue and earnings than Envista. Align Technology is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.72B	1.52	$47M	$0.41	61.78
Align Technology	$4.03B	2.99	$410.35M	$5.96	28.27

In the previous week, Align Technology had 5 more articles in the media than Envista. MarketBeat recorded 5 mentions for Align Technology and 0 mentions for Envista. Envista's average media sentiment score of 0.89 beat Align Technology's score of 0.48 indicating that Envista is being referred to more favorably in the media.

Company	Overall Sentiment
Envista	Positive
Align Technology	Neutral

Envista has a beta of 0.88, meaning that its share price is 12% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.67, meaning that its share price is 67% more volatile than the broader market.

Envista presently has a consensus price target of $28.67, indicating a potential upside of 13.17%. Align Technology has a consensus price target of $205.85, indicating a potential upside of 22.17%. Given Align Technology's stronger consensus rating and higher probable upside, analysts clearly believe Align Technology is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40
Align Technology	0 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.71

Summary

Align Technology beats Envista on 15 of the 17 factors compared between the two stocks.

How does Envista compare to DENTSPLY SIRONA?

DENTSPLY SIRONA (NASDAQ:XRAY) and Envista (NYSE:NVST) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, profitability, valuation, earnings, institutional ownership and risk.

DENTSPLY SIRONA currently has a consensus price target of $13.55, suggesting a potential upside of 32.80%. Envista has a consensus price target of $28.67, suggesting a potential upside of 13.17%. Given DENTSPLY SIRONA's higher probable upside, equities analysts clearly believe DENTSPLY SIRONA is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	3 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40

Envista has a net margin of 2.41% compared to DENTSPLY SIRONA's net margin of -17.06%. DENTSPLY SIRONA's return on equity of 18.83% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-17.06%	18.83%	5.13%
Envista	2.41%	7.11%	3.91%

95.7% of DENTSPLY SIRONA shares are owned by institutional investors. 0.5% of DENTSPLY SIRONA shares are owned by company insiders. Comparatively, 1.0% of Envista shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Envista has lower revenue, but higher earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.68B	0.56	-$598M	-$3.15	N/A
Envista	$2.72B	1.52	$47M	$0.41	61.78

In the previous week, DENTSPLY SIRONA had 4 more articles in the media than Envista. MarketBeat recorded 4 mentions for DENTSPLY SIRONA and 0 mentions for Envista. DENTSPLY SIRONA's average media sentiment score of 1.33 beat Envista's score of 0.89 indicating that DENTSPLY SIRONA is being referred to more favorably in the media.

Company	Overall Sentiment
DENTSPLY SIRONA	Positive
Envista	Positive

DENTSPLY SIRONA has a beta of 0.89, meaning that its stock price is 11% less volatile than the broader market. Comparatively, Envista has a beta of 0.88, meaning that its stock price is 12% less volatile than the broader market.

Summary

DENTSPLY SIRONA and Envista tied by winning 8 of the 16 factors compared between the two stocks.

How does Envista compare to BellRing Brands?

BellRing Brands (NYSE:BRBR) and Envista (NYSE:NVST) are related companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, earnings, dividends, analyst recommendations, valuation and profitability.

BellRing Brands has higher earnings, but lower revenue than Envista. BellRing Brands is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BellRing Brands	$2.32B	0.57	$216.20M	$1.29	8.78
Envista	$2.72B	1.52	$47M	$0.41	61.78

BellRing Brands has a net margin of 6.78% compared to Envista's net margin of 2.41%. Envista's return on equity of 7.11% beat BellRing Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BellRing Brands	6.78%	-44.06%	19.42%
Envista	2.41%	7.11%	3.91%

BellRing Brands has a beta of 0.56, suggesting that its share price is 44% less volatile than the broader market. Comparatively, Envista has a beta of 0.88, suggesting that its share price is 12% less volatile than the broader market.

BellRing Brands currently has a consensus price target of $22.47, suggesting a potential upside of 98.47%. Envista has a consensus price target of $28.67, suggesting a potential upside of 13.17%. Given BellRing Brands' higher probable upside, equities analysts plainly believe BellRing Brands is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BellRing Brands	2 Sell rating(s)	8 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.37
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40

In the previous week, BellRing Brands had 3 more articles in the media than Envista. MarketBeat recorded 3 mentions for BellRing Brands and 0 mentions for Envista. BellRing Brands' average media sentiment score of 1.53 beat Envista's score of 0.89 indicating that BellRing Brands is being referred to more favorably in the media.

Company	Overall Sentiment
BellRing Brands	Very Positive
Envista	Positive

95.0% of BellRing Brands shares are held by institutional investors. 1.5% of BellRing Brands shares are held by insiders. Comparatively, 1.0% of Envista shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

BellRing Brands beats Envista on 10 of the 16 factors compared between the two stocks.

How does Envista compare to Solventum?

Envista (NYSE:NVST) and Solventum (NYSE:SOLV) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, profitability, analyst recommendations, earnings and media sentiment.

Envista currently has a consensus target price of $28.67, suggesting a potential upside of 13.17%. Solventum has a consensus target price of $84.25, suggesting a potential upside of 13.64%. Given Solventum's stronger consensus rating and higher possible upside, analysts clearly believe Solventum is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40
Solventum	1 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.50

Solventum has a net margin of 17.33% compared to Envista's net margin of 2.41%. Solventum's return on equity of 23.51% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	2.41%	7.11%	3.91%
Solventum	17.33%	23.51%	7.63%

Envista has a beta of 0.88, indicating that its share price is 12% less volatile than the broader market. Comparatively, Solventum has a beta of 0.69, indicating that its share price is 31% less volatile than the broader market.

In the previous week, Solventum had 3 more articles in the media than Envista. MarketBeat recorded 3 mentions for Solventum and 0 mentions for Envista. Envista's average media sentiment score of 0.89 beat Solventum's score of 0.25 indicating that Envista is being referred to more favorably in the media.

Company	Overall Sentiment
Envista	Positive
Solventum	Neutral

Solventum has higher revenue and earnings than Envista. Solventum is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.72B	1.52	$47M	$0.41	61.78
Solventum	$8.33B	1.54	$1.56B	$8.16	9.09

Summary

Solventum beats Envista on 11 of the 14 factors compared between the two stocks.

How does Envista compare to Smith & Nephew SNATS?

Smith & Nephew SNATS (NYSE:SNN) and Envista (NYSE:NVST) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, media sentiment, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations.

25.6% of Smith & Nephew SNATS shares are owned by institutional investors. 1.0% of Smith & Nephew SNATS shares are owned by company insiders. Comparatively, 1.0% of Envista shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Envista has a net margin of 2.41% compared to Smith & Nephew SNATS's net margin of 0.00%. Envista's return on equity of 7.11% beat Smith & Nephew SNATS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Smith & Nephew SNATS	N/A	N/A	N/A
Envista	2.41%	7.11%	3.91%

In the previous week, Envista's average media sentiment score of 0.89 beat Smith & Nephew SNATS's score of 0.00 indicating that Envista is being referred to more favorably in the news media.

Company	Overall Sentiment
Smith & Nephew SNATS	Neutral
Envista	Positive

Smith & Nephew SNATS has higher revenue and earnings than Envista.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Smith & Nephew SNATS	$6.16B	2.04	$625M	N/A	N/A
Envista	$2.72B	1.52	$47M	$0.41	61.78

Smith & Nephew SNATS presently has a consensus target price of $30.93, indicating a potential upside of 4.41%. Envista has a consensus target price of $28.67, indicating a potential upside of 13.17%. Given Envista's stronger consensus rating and higher possible upside, analysts clearly believe Envista is more favorable than Smith & Nephew SNATS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Smith & Nephew SNATS	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40

Smith & Nephew SNATS has a beta of 0.55, suggesting that its share price is 45% less volatile than the broader market. Comparatively, Envista has a beta of 0.88, suggesting that its share price is 12% less volatile than the broader market.

Summary

Envista beats Smith & Nephew SNATS on 8 of the 13 factors compared between the two stocks.

Get Envista News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NVST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NVST vs. The Competition

Export

Metric	Envista	MED PRODUCTS Industry	Medical Sector	NYSE Exchange
Market Cap	$4.15B	$8.06B	$6.46B	$23.15B
Dividend Yield	N/A	2.55%	2.68%	4.06%
P/E Ratio	19.33	15.24	24.71	31.08
Price / Sales	1.52	5.50	492.47	108.25
Price / Cash	11.75	17.32	27.92	18.65
Price / Book	1.34	3.22	10.82	4.65
Net Income	$47M	$226.25M	$3.56B	$1.07B
7 Day Performance	2.31%	-3.57%	1.67%	-1.04%
1 Month Performance	8.22%	-3.72%	0.43%	0.18%
1 Year Performance	34.02%	1.93%	32.84%	24.25%

Envista Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NVST Envista	2.3692 of 5 stars	$25.33 -0.7%	$28.67 +13.2%	+35.1%	$4.15B	$2.72B	19.33	12,000
ALGN Align Technology	4.1493 of 5 stars	$178.26 +2.0%	$205.85 +15.5%	-4.4%	$12.52B	$4.03B	29.91	20,290
XRAY DENTSPLY SIRONA	4.9617 of 5 stars	$10.14 +0.5%	$13.55 +33.6%	-33.9%	$2.02B	$3.68B	N/A	14,000	Positive News
BRBR BellRing Brands	4.5976 of 5 stars	$8.84 +0.3%	$22.47 +154.1%	-82.6%	$1.02B	$2.32B	6.85	380	Positive News
SOLV Solventum	3.4852 of 5 stars	$76.85 -2.6%	$84.25 +9.6%	-0.1%	$13.66B	$8.33B	9.42	20,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:NVST) was last updated on 6/23/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Envista (NVST) Competitors

NVST vs. ALGN, XRAY, BRBR, SOLV, and SNN

How does Envista compare to Align Technology?

Summary

How does Envista compare to DENTSPLY SIRONA?

Summary

How does Envista compare to BellRing Brands?

Summary

How does Envista compare to Solventum?

Summary

How does Envista compare to Smith & Nephew SNATS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NVST vs. The Competition

Envista Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Envista (NVST) Competitors

NVST vs. ALGN, XRAY, BRBR, SOLV, and SNN

How does Envista compare to Align Technology?

Do institutionals and insiders believe in NVST or ALGN?

Is NVST or ALGN more profitable?

Which has preferable valuation & earnings, NVST or ALGN?

Does the media prefer NVST or ALGN?

Which has more volatility & risk, NVST or ALGN?

Do analysts recommend NVST or ALGN?

Summary

How does Envista compare to DENTSPLY SIRONA?

Do analysts prefer XRAY or NVST?

Is XRAY or NVST more profitable?

Do insiders and institutionals hold more shares of XRAY or NVST?

Which has higher valuation & earnings, XRAY or NVST?

Does the media favor XRAY or NVST?

Which has more volatility & risk, XRAY or NVST?

Summary

How does Envista compare to BellRing Brands?

Which has preferable earnings & valuation, BRBR or NVST?

Is BRBR or NVST more profitable?

Which has more volatility & risk, BRBR or NVST?

Do analysts prefer BRBR or NVST?

Does the media favor BRBR or NVST?

Do institutionals & insiders have more ownership in BRBR or NVST?

Summary

How does Envista compare to Solventum?

Do analysts rate NVST or SOLV?

Is NVST or SOLV more profitable?

Which has more risk & volatility, NVST or SOLV?

Does the media refer more to NVST or SOLV?

Which has better earnings and valuation, NVST or SOLV?

Summary

How does Envista compare to Smith & Nephew SNATS?

Do institutionals and insiders hold more shares of SNN or NVST?

Is SNN or NVST more profitable?

Does the media favor SNN or NVST?

Which has better earnings & valuation, SNN or NVST?

Do analysts rate SNN or NVST?

Which has more risk and volatility, SNN or NVST?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NVST vs. The Competition

Envista Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools